2. Findings and Diagnosis

15479 This is a CT scan of the adrenal with findings that include a nodule in the left adrenal. The lack of perfusion in the spleen was shown at autopsy to be due to diffuse infiltration of amyloid in this patient with amyloidosis. (see 15349 -52) Courtesy Ashley Davidoff MD. infiltrative
Page 2 – Findings and Diagnosis (Fx and Dx)
Under-Image Caption (Three-Paragraph Format)
Diffuse Splenic Non-Enhancement in Amyloidosis
CT shows diffuse hypoattenuation of the spleen, consistent with non-enhancement in the setting of systemic amyloidosis.
Courtesy: Ashley Davidoff MD, TheCommonVein.com (15479)
Table 1 – U-SSPCT–C Analysis
Parameter |
Description |
Units (U) |
Spleen (primary unit), adrenal gland (secondary finding) |
Size |
Spleen normal to slightly enlarged; adrenal nodule ~1.5 cm |
Shape |
Spleen: smooth; adrenal: round |
Position |
LUQ (spleen); right adrenal superior to kidney |
Character |
Diffuse non-enhancement of spleen; adrenal is solid and mildly hyperdense |
Time |
Chronic pattern suspected (systemic amyloidosis) |
Connections |
Spleen: part of lymphatic and immune system; adrenal: endocrine system |
Clinical Context |
Patient with known amyloidosis; systemic infiltration likely |
Table 2 – Differential Diagnosis
Table 2a – Most Likely Diagnosis
Diagnosis |
Rationale |
Amyloidosis |
Known systemic disease; characteristic non-enhancing spleen; adrenal involvement common |
Table 2b – Other Considerations (IINMTM–CIIIIFPP)
Category |
Example Diagnosis |
Why Considered |
Inflammatory / Immune |
Sarcoidosis |
Non-caseating granulomas may infiltrate spleen |
Infection |
Tuberculosis |
May affect spleen in disseminated form |
Neoplasm – Malignant (Primary) |
Lymphoma |
Common cause of diffuse splenic infiltration |
Neoplasm – Malignant (Metastatic) |
Melanoma |
May spread to spleen and adrenal |
Trauma |
Splenic infarction |
Rare but mimics non-enhancement |
Metabolic |
Gaucher’s Disease |
Infiltrative pattern, hepatosplenomegaly |
Circulatory |
Splenic infarcts |
Hypoperfused spleen |
Inherited |
Sickle Cell |
Functional asplenia from infarction |
Table 3 – Imaging Diagnosis: Strategies and Guidelines
Imaging Modality |
Use in Diagnosis |
When / Why Used |
Guideline / Reference |
CT (Contrast) |
Evaluates enhancement, infarction, infiltration |
First-line for hypoattenuating spleen |
ACR Appropriateness Criteria®: Splenomegaly or Splenic Mass https://acsearch.acr.org/list/GenerateAppendixPDF?TopicId=130 |
MRI |
Superior for tissue characterization, vascularity, infiltration |
Follow-up for CT, or first-line in younger/renal-risk patients |
Radiology White Paper: Infiltrative Disease Imaging https://www.jacr.org/article/S1546-1440(13)00305-0/abstract |
Ultrasound |
Assesses size, echotexture, splenic contour |
First-line for splenomegaly or incidental findings |
AIUM Practice Parameters https://www.aium.org/resources/practice-parameters |
Nuclear Medicine |
Functional studies (e.g., colloid scan for splenic activity) |
Rarely used; for infarct or asplenia suspicion |
SNMMI Guidelines: Liver and Spleen Scintigraphy https://www.snmmi.org/Web/Web/Clinical-Practice/Procedure-Standards |
Image-Guided Biopsy |
Diagnostic confirmation (e.g., amyloid, lymphoma) |
Reserved for unclear/inconclusive imaging or to guide treatment |
SIR Guidelines: Image-Guided Biopsy https://www.sirweb.org/in-practice/guidelines-and-statements/ |
3. Clinical
Page 4 – Clinical (Diagnosis-Focused: Systemic Amyloidosis with Splenic Involvement)
Domain |
Details |
Diagnosis |
Systemic Amyloidosis (AL or AA types) with splenic involvement |
Etiology |
Misfolded protein deposition — AL (light chain from plasma cell dyscrasia), AA (serum amyloid A from chronic inflammation/infection) |
Structural Change |
Amyloid replaces splenic tissue, leading to decreased vascularity, infarction, possible size changes |
Functional Change |
Loss of immune filtering, increased infection risk, possible cytopenias due to splenic sequestration |
Clinical Features |
Fatigue, weight loss, splenomegaly, cytopenias, nephrotic syndrome, macroglossia, periorbital purpura |
Key Lab Tests |
CBC (cytopenias), SPEP/UPEP (monoclonal spike), Free light chains (kappa/lambda ratio), Biopsy (Congo red positivity, apple-green birefringence) |
Treatment Strategies |
AL: Chemotherapy (bortezomib-based); AA: Treat underlying cause. Supportive care includes vaccines and organ-directed therapies |
Risk Considerations |
Functional asplenia (infection risk), renal failure, cardiac amyloidosis, bleeding tendencies |
4. Historical and Cultural
Page 5 – History, Culture, and Art
1. History of Disease Recognition
Aspect |
Details |
First Descriptions |
Term “amyloid” coined by Rudolf Virchow in 1854, mistakenly thought to be starch-like. |
Clarification |
Later confirmed to be proteinaceous in origin, not carbohydrate. |
Early Observations |
Involved organs like the liver, spleen, and kidney in patients with chronic infections. |
2. History of Diagnosis
Aspect |
Details |
Congo Red Stain |
Introduced in early 20th century; apple-green birefringence under polarized light became the gold standard. |
Biopsy Sites |
Fat pad aspiration and organ-specific biopsies became common. |
Recent Advances |
Mass spectrometry used to subtype amyloid fibrils. |
3. History of Imaging
Modality |
Relevance |
CT |
Shows non-enhancing or hypoattenuated spleen due to loss of perfusion. |
MRI |
May show low signal on all sequences; delayed enhancement. |
Radionuclide Scans |
SAP scintigraphy used in Europe to track amyloid burden (limited availability). |
4. History of Laboratory Testing
Test |
Evolution |
SPEP/UPEP |
Became standard for detecting monoclonal light chains. |
Free Light Chain Assay |
Developed to improve sensitivity and specificity in plasma cell disorders. |
5. History of Treatment
Era |
Approach |
Pre-2000 |
Supportive care only; poor prognosis. |
2000s |
Use of chemotherapy borrowed from myeloma (melphalan, dexamethasone). |
2010s–Present |
Proteasome inhibitors (e.g., bortezomib), stem cell transplantation, and novel biologics. |
6. Cultural Meaning and Symbolism
Theme |
Interpretation |
Invisibility |
Amyloidosis is often termed a “zebra” due to its rarity and hidden nature. |
Crystal and Stiffness |
Symbolic of rigidity and fragility, as amyloid infiltrates solidify soft organs. |
7. Artistic Representation
Medium |
Example |
Microscopic Imaging |
Congo red birefringence under polarized light has become an iconic educational image in pathology. |
Medical Illustration |
Organ cross-sections with waxy deposition shown in autopsy texts and anatomy atlases. |
8. Notable Figures
Person |
Role |
Rudolf Virchow |
Coined the term “amyloid”; key figure in cellular pathology. |
Sir Mark Pepys |
Leading researcher in SAP imaging and amyloidosis treatment. |
9. Quotes
Quote |
Author |
“Diseases of the spleen often whisper before they scream.” |
Attributed to 20th century internists – common in internal medicine lore |
5. MCQs
✅ MCQ 1 – Basic Science
Which of the following stains is most characteristic for confirming amyloid in tissue samples?
A. PAS
B. Congo red
C. Masson trichrome
D. Giemsa
Correct Answer |
Explanation |
B. Congo red |
Congo red binds amyloid fibrils, showing apple-green birefringence under polarized light – diagnostic hallmark. |
Incorrect Option |
Why Incorrect |
A. PAS |
Stains glycogen and mucopolysaccharides, not specific to amyloid. |
C. Masson trichrome |
Differentiates collagen (blue/green) and muscle, not used for amyloid. |
D. Giemsa |
Used for blood cells and microbes; not amyloid-specific. |
✅ MCQ 2 – Basic Science
Amyloidosis primarily involves which of the following abnormal protein conformations?
A. Alpha-helix
B. Beta-pleated sheet
C. Triple helix
D. Random coil
Correct Answer |
Explanation |
B. Beta-pleated sheet |
Amyloid fibrils adopt beta-pleated sheet conformation, leading to abnormal aggregation. |
Incorrect Option |
Why Incorrect |
A. Alpha-helix |
Normal structure of many proteins, not pathological in amyloidosis. |
C. Triple helix |
Structure of collagen, unrelated to amyloid. |
D. Random coil |
Lacks stable secondary structure, not associated with amyloid. |
✅ MCQ 3 – Clinical
Which systemic complication is most commonly associated with AL amyloidosis?
A. Hemorrhagic stroke
B. Nephrotic syndrome
C. Diabetes insipidus
D. Hypocalcemia
Correct Answer |
Explanation |
B. Nephrotic syndrome |
AL amyloid commonly deposits in glomeruli, disrupting filtration → proteinuria and hypoalbuminemia. |
Incorrect Option |
Why Incorrect |
A. Hemorrhagic stroke |
Rare in amyloidosis. |
C. Diabetes insipidus |
More common in hypothalamic or pituitary disease. |
D. Hypocalcemia |
Unrelated unless kidney damage is extreme. |
✅ MCQ 4 – Clinical
Which of the following therapies is most appropriate for AL amyloidosis?
A. Antibiotics
B. Bortezomib
C. Insulin
D. Statins
Correct Answer |
Explanation |
B. Bortezomib |
A proteasome inhibitor used to reduce plasma cell dyscrasia driving light chain production. |
Incorrect Option |
Why Incorrect |
A. Antibiotics |
Not first-line unless secondary infection. |
C. Insulin |
Not relevant to amyloid pathology. |
D. Statins |
Treat lipids, not protein misfolding. |
✅ MCQ 5 – Radiologic
Which imaging feature is most characteristic of splenic involvement in systemic amyloidosis?
A. Hypodense non-enhancing spleen on CT
B. Splenic calcification on X-ray
C. Diffuse increased FDG uptake on PET
D. Enlarged spleen with fat stranding
Correct Answer |
Explanation |
A. Hypodense non-enhancing spleen on CT |
Reflects reduced perfusion due to amyloid infiltration. |
Incorrect Option |
Why Incorrect |
B. Splenic calcification |
Nonspecific; not typical for amyloid. |
C. Increased FDG uptake |
Amyloid often shows decreased metabolic activity. |
D. Fat stranding |
More typical of inflammation, not amyloidosis. |
✅ MCQ 6 – Radiologic
What nuclear medicine technique is used to track systemic amyloid deposits?
A. Technetium-99m MIBI
B. Iodine-131 MIBG
C. Serum amyloid P component (SAP) scintigraphy
D. Gallium-67 scan
Correct Answer |
Explanation |
C. SAP scintigraphy |
Binds selectively to amyloid deposits, used for staging and follow-up in some centers. |
Incorrect Option |
Why Incorrect |
A. Tc-99m MIBI |
Used in myocardial perfusion imaging. |
B. I-131 MIBG |
For neuroendocrine tumors, not amyloid. |
D. Gallium-67 |
Inflammatory conditions, not specific to amyloid. |
✅ MCQ 7 – Radiologic
Which CT pattern suggests adrenal amyloid involvement?
A. Hyperenhancing adrenal nodule
B. Fat-containing lesion with calcifications
C. Non-enhancing hypodense mass
D. Enhancing lesion with central necrosis
Correct Answer |
Explanation |
C. Non-enhancing hypodense mass |
Amyloid deposits cause poor perfusion and hypoattenuation. |
Incorrect Option |
Why Incorrect |
A. Hyperenhancing lesion |
Suggests pheochromocytoma or adenoma. |
B. Fat and calcifications |
Suggests myelolipoma. |
D. Central necrosis |
More typical of carcinoma or metastasis. |
6. Memory Image
Page 7 – Memory Image Table
Component |
Description |
Visual Metaphor Title |
“The Frozen Sponge” |
Conceptual Image |
A once-vibrant red sponge (symbolizing the spleen) now frozen in translucent crystalline layers, resting dry and colorless beside a dull river of stalled blood. |
Anatomy Representation |
The sponge = spleen; the splenic architecture is normally porous, dynamic, and richly vascularized. |
Physiologic Meaning |
A functioning spleen filters blood, removes pathogens and senescent cells — a living immune sponge. |
Pathologic Interpretation |
In amyloidosis, the “freeze” represents amyloid infiltration. Protein deposits harden the sponge, cutting off blood flow — hence the visual of a frozen, non-perfused organ. |
Imaging Parallel |
On CT, the spleen shows diffuse hypoattenuation (non-enhancement), as if perfusion is literally frozen in time. |
Emotional/Memory Hook |
The transformation from living filter to lifeless ice reinforces the concept of functional loss due to infiltration — frozen structure, frozen function. |
Challenge
2. Findings and Diagnosis
3. Clinical
4. Historical and Cultural
5. MCQs
6. Memory Image